National Genomics Infrastructure becomes first global certified core lab for Epigenica’s EpiFinder platform
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
The multi-target collaboration combines Regeneron’s industry-leading antibody capabilities with Parabilis’ novel Helicon peptide platform
The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
The company intends to file an IND submission by the end of this year and begin clinical studies in 2027
The global diagnostics supplier said the multi-phase expansion aims to deliver more than 60 commercially available recombinant antigen products by 2030
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges
Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios
Subscribe To Our Newsletter & Stay Updated